Neutra Corp.

Neutra Corp Targets Expanded Sponsor and CRO Relationships in Q3 & Q4 2026, Reaffirming Full Commitment to Life Sciences Growth

Neutra Corp announced a strategic refocusing of its corporate resources to drive the growth of its wholly owned subsidiary, Neutra Life Sciences, a clinical research Site Management Organization. The company plans to accelerate outreach to clinical trial sponsors and CROs throughout the second half of 2026, targeting visibility at industry conferences including the SCRS Global Site Solutions Summit and Obesity Week 2026. As part of this realignment, Neutra Corp entered into a Securities Purchase Agreement Reversal and Debt Settlement Agreement with VIVIS Corporation to align capital behind its core life sciences strategy.

•3mo ago

Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio

Neutra Corp’s subsidiary Neutra Life Sciences formed a joint venture with the Women’s Healthcare Center of Baytown to expand its site network into women’s health. The subsidiary was also awarded new clinical trials in Oncology, Dermatology, Pulmonology, and Women’s Health while securing contracts with new sponsors. Management indicated that these milestones mark a transition from an early-growth phase to a stable operating model capable of scaling trial volume for the remainder of 2026.

•3mo ago